Unprotected left main coronary artery stenting for cardiac allograft vasculopathy.
Cardiac allograft vasculopathy is the leading cause of death after the first year of transplantation. Treatment outcomes with medication, balloon angioplasty, bypass surgery, and retransplantation have been disappointing. We present our initial experience with stenting of the left main coronary artery in the setting of allograft vasculopathy.
Chan
A W
AW
Division of Cardiology, St. Paul's Hospital, Vancouver, British Columbia, Canada.
Carere
R G
RG
Khatri
S
S
Della Siega
A
A
Ignaszewski
A P
AP
Webb
J G
JG
D015906:Angioplasty, Balloon, Coronary / Q000379:methods*; D000925:Anticoagulants / Q000627:therapeutic use; D017023:Coronary Angiography; D003327:Coronary Disease / Q000209:etiology* / Q000601:surgery*; D005260:Female; D016027:Heart Transplantation / Q000009:adverse effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009204:Myocardial Revascularization / Q000379:methods*; D015607:Stents; D014184:Transplantation, Homologous / Q000009:adverse effects
D000925:Anticoagulants